Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathomechanisms of Blood-Brain Barrier Disruption in ALS
Nicholas Kakaroubas, Samuel Brennan, Matthew Keon, et al.
Neuroscience Journal (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Mitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases
Paweł Kowalczyk, Dorota Sulejczak, Patrycja Kleczkowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13384-13384
Open Access | Times Cited: 252
In Vitro Models of the Blood-Brain Barrier
Winfried Neuhaus
Handbook of experimental pharmacology (2020), pp. 75-110
Closed Access | Times Cited: 225
Antioxidant nanozymes as next-generation therapeutics to free radical-mediated inflammatory diseases: A comprehensive review
Sanjay Singh
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129374-129374
Closed Access | Times Cited: 17
Oxidative Stress-Mediated Blood-Brain Barrier (BBB) Disruption in Neurological Diseases
Ke Song, Yuanyuan Li, Hanlai Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-27
Open Access | Times Cited: 133
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Brain Research Bulletin (2020) Vol. 160, pp. 121-140
Closed Access | Times Cited: 99
The role of amyloid oligomers in neurodegenerative pathologies
Cameron I. Wells, Samuel Brennan, Matt Keon, et al.
International Journal of Biological Macromolecules (2021) Vol. 181, pp. 582-604
Open Access | Times Cited: 80
Sex differences in the blood–brain barrier and neurodegenerative diseases
Callie M. Weber, Alisa Morss Clyne
APL Bioengineering (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 59
Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
Moritz Steinruecke, Rebecca Murphy Lonergan, Bhuvaneish T. Selvaraj, et al.
Journal of Cerebral Blood Flow & Metabolism (2023) Vol. 43, Iss. 5, pp. 642-654
Open Access | Times Cited: 27
Most recent advances and applications of extracellular vesicles in tackling neurological challenges
Mandeep Kaur, Salvatore Fusco, Bram Van den Broek, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1923-1966
Open Access | Times Cited: 8
Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice
Yongguo Zhang, Yinglin Xia, Jun Sun
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Destination Amyotrophic Lateral Sclerosis
Matt Keon, Benjamin Musrie, Marcel E. Dinger, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 41
Elevated PDGF‐BB from Bone Impairs Hippocampal Vasculature by Inducing PDGFRβ Shedding from Pericytes
Guanqiao Liu, Jiekang Wang, Zhiliang Wei, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 20
Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease
Shalini Mani, Rajni Dubey, I‐Chun Lai, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 3, pp. 877-912
Closed Access | Times Cited: 19
Rational Design and Biological Application of Antioxidant Nanozymes
Ruizhen Tian, Jiayun Xu, Quan Luo, et al.
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 40
Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine
Hariharan Moorthy, Thimmaiah Govindaraju
ACS Applied Bio Materials (2021) Vol. 4, Iss. 2, pp. 1115-1139
Closed Access | Times Cited: 37
Delayed Onset Muscle Soreness (DOMS): The Repeated Bout Effect and Chemotherapy-Induced Axonopathy May Help Explain the Dying-Back Mechanism in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
Balázs Sonkodi
Brain Sciences (2021) Vol. 11, Iss. 1, pp. 108-108
Open Access | Times Cited: 36
Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
Weiyi Yu, Ji He, Xiying Cai, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 25
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
Sarah Jacob, Suk‐young Lee, Seung Hyun Kim, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 475-494
Closed Access | Times Cited: 5
Senescence-associated microvascular endothelial dysfunction: A focus on the blood-brain and blood-retinal barriers
Sung Young Kim, J E Cheon
Ageing Research Reviews (2024) Vol. 100, pp. 102446-102446
Closed Access | Times Cited: 4
Neurofilament light chain (Nf-L) in cerebrospinal fluid and serum as a potential biomarker in the differential diagnosis of neurological diseases in cattle
Giorgia Di Muro, Carlotta Tessarolo, Giulia Cagnotti, et al.
Veterinary Research (2025) Vol. 56, Iss. 1
Open Access
Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut–Brain Axis and Therapeutic Potential of Microbiota Modulation
Victòria Ayala, Laia Fontdevila, Santiago Rico-Rios, et al.
Sclerosis (2025) Vol. 3, Iss. 1, pp. 8-8
Open Access
A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10900-10900
Open Access | Times Cited: 4
Dysfunction of the neurovascular unit in diabetes-related neurodegeneration
Caochong Yan, Yunxiang Zhou, Qiang Chen, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110656-110656
Open Access | Times Cited: 28
Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders
Mariana Kolesárová, Patrik Šimko, Nicol Urbanská, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 204-204
Open Access | Times Cited: 9
Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers
Hossam Kadry, Behnam Noorani, Ulrich Bickel, et al.
Fluids and Barriers of the CNS (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top